To view this email as a web page, click here.
Conference Coverage
 
 October 31, 2018
 
The Fall Clinical Dermatology Conference recently wrapped in Las Vegas. Visit our conference page for our news reports from the meeting.
 
Good skin health and a diverse microbiome go hand-in-hand
Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.
 
Psoriasis topical works better as a lotion
Researcher experiments with reformulating psoriasis topical as a lotion instead of cream, which performed well with patients.
 
Cosmeceutical therapies on the horizon
In a presentation at the Fall Clinical Dermatology Conference held on Saturday in Las Vegas, Diane Berson, M.D., outlined trends and new ingredients in oral and topical cosmeceuticals.
 
More new therapies under study for underarm sweat
Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.
 
Treatment options for benign lesions
Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.
 
Four effective anti-IL 23 drugs for psoriasis
Two approved and two pending anti-IL 23 drugs offer an opportunity for moderate to severe psoriasis patients to regain their lives, according to researchers presenting at the 2018 Fall Clinical Dermatology Conference.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.